Last reviewed · How we verify
NCT06282354
Telemedicine for Postoperative Follow-up After Oncological Surgeries
trial testing Type of post-operative appointment in Urologic Cancer in 200 participants. Status unknown.
15 August 2024
Quick facts
| Lead sponsor | Instituto do Cancer do Estado de São Paulo |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 March 2024 |
| Primary completion | 15 August 2024 |
| Estimated completion | 15 February 2025 |
Drugs / interventions tested
- Type of post-operative appointment
Conditions studied
- Urologic Cancer — all drugs for Urologic Cancer →
- Satisfaction, Patient — all drugs for Satisfaction, Patient →
- Surgery — all drugs for Surgery →
- Postoperative Adhesion — all drugs for Postoperative Adhesion →
Sponsor
Instituto do Cancer do Estado de São Paulo — full company profile →
Who can join
18 and older, any sex, with Urologic Cancer or Satisfaction, Patient. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will be a prospective, randomized, non-inferiority, open-label study, to be carried out at the Cancer Institute of the State of São Paulo for 6 months and will include patients agreeing to voluntary participation upon signing an informed consent form.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06282354
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urologic Cancer
Currently open trials in the same condition.
- NCT06397287 — PROM Project Urology · recruiting
- NCT07416630 — Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients · NA · recruiting
- NCT05899361 — A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest · NA · recruiting
- NCT05725304 — The Registry of Genetic Expression of Taiwan Urologic Cancer · active not recruiting
- NCT06357416 — The Man Van Project · NA · recruiting
Other Instituto do Cancer do Estado de São Paulo trials
Trials by the same sponsor.
- NCT06887621 — Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk f · Phase 2 · recruiting
- NCT07066046 — Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions · NA · recruiting
- NCT05622136 — Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma · Phase 2 · active not recruiting
- NCT05996367 — Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma · NA · recruiting
- NCT06070376 — Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06282354 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto do Cancer do Estado de São Paulo
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06282354.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing